Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients.

Clinical trial NCT02831543 · UNKNOWN

Trial details

NCT number: NCT02831543
Sponsor: IlDong Pharmaceutical Co Ltd
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Functional Dyspepsia

Start date: 2016-04-01
Primary completion: 2017-01-01
Enrollment: 354

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.